Centiva Capital’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-25,911
| Closed | -$1.96M | – | 2011 |
|
|
2026
Q1 | $1.96M | Sell |
25,911
-89,389
| -78% | -$6.72M | 0.01% | 435 |
|
|
2025
Q4 | $8.59M | Buy |
+115,300
| New | +$8.42M | 0.07% | 181 |
|
|
2025
Q3 | – | Sell |
-10,839
| Closed | -$706K | – | 1424 |
|
|
2025
Q2 | $706K | Sell |
10,839
-779
| -7% | -$46.7K | 0.01% | 789 |
|
|
2025
Q1 | $718K | Sell |
11,618
-15,697
| -57% | -$1.04M | 0.02% | 636 |
|
|
2024
Q4 | $1.97M | Buy |
+27,315
| New | +$2.13M | 0.04% | 340 |
|
|
2024
Q2 | – | Sell |
-4,923
| Closed | -$384K | – | 2261 |
|
|
2024
Q1 | $384K | Sell |
4,923
-11,824
| -71% | -$880K | 0.01% | 1121 |
|
|
2023
Q4 | $1.2M | Buy |
16,747
+1,507
| +10% | +$105K | 0.03% | 530 |
|
|
2023
Q3 | $1.06M | Buy |
+15,240
| New | +$1.15M | 0.02% | 609 |
|
|
2023
Q2 | – | Sell |
-11,024
| Closed | -$890K | – | 1780 |
|
|
2023
Q1 | $890K | Buy |
+11,024
| New | +$887K | 0.02% | 642 |
|
|
2022
Q3 | – | Sell |
-6,145
| Closed | -$426K | – | 1644 |
|
|
2022
Q2 | $426K | Buy |
+6,145
| New | +$456K | 0.01% | 986 |
|
|
2021
Q2 | – | Sell |
-3,867
| Closed | -$288K | – | 1481 |
|
|
2021
Q1 | $288K | Sell |
3,867
-635
| -14% | -$48.2K | 0.01% | 810 |
|
|
2020
Q4 | $328K | Buy |
+4,502
| New | +$318K | 0.01% | 624 |
|
|
2020
Q2 | – | Sell |
-4,568
| Closed | -$224K | – | 728 |
|
|
2020
Q1 | $160K | Buy |
+4,568
| New | +$217K | 0.01% | 460 |
|
Other funds holding HOLX
Centiva Capital's HOLX Position: Q2 2026 in Review
Centiva Capital sold out of Hologic (HOLX) in Q2 2026, closing a stake of 25,911 shares — an estimated $1.96M sold.
Centiva Capital first reported a position in HOLX in Q1 2020 and held it in 13 quarters. The position peaked at $8.59M in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Centiva Capital reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Centiva Capital sold 25,911 Hologic shares in Q2 2026, an estimated $1.96M.
- Centiva Capital first reported a position in Hologic in Q1 2020 and held it in 13 quarters.
- Centiva Capital's Hologic position peaked at $8.59M in Q4 2025.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.